APOBEC3B and adenocarcinoma: Recent studies in TCGA tumors uncovered elevated expression of A3B in breast, bladder, cervix, lung (adenocarcinoma and squamous cell carcinoma), and head and neck cancers, and addressed the role of A3B in mediating genomic mutations19, 20.